Table 1.

Patient Characteristics (N=46)

Characteristic	Study Group
	LLLT (N=15)	MLD (N=16)	Combined MLD & LLLT (N=15)
	n (%)	n (%)	n (%)
Marital Status
Married	12 (80.0)	9 (56.2)	6 (40.0)
Not married	3 (20.0)	7 (43.7)	9 (60.0)
Work Status
Retired	8 (53.3)	12 (75.0)	9 (60.0)
Employed	5 (33.3)	3 (18.7)	3 (20.0)
Unemployed	2 (13.3)	1 (6.2)	3 (20.0)
Insurance Status
Government Insurance	10 (66.7)	11 (68.8)	9 (60.0)
Private Insurance	4 (26.7)	5 (31.2)	5 (33.3)
None	1 (6.7)	0 (0.0)	1 (6.7)
Residence*
City	11 (73.3)	9 (56.2)	6 (40.0)
Other	3 (20.0)	2 (12.5)	8 (53.3)
Country	1 (6.7)	5 (31.2)	1 (6.7)
Income
≤$50,000	9 (60.0)	10 (66.6)	6 (40.1)
>$50,000	5 (33.4)	4 (26.7)	6 (40.0)
Do not care to respond	1 (6.7)	1 (6.7)	3 (20.0)
Race
Caucasian	14 (93.3)	15 (93.8)	15 (100.0)
African American	1 (6.7)	1 (6.2)	0 (0.0)
Education
Grades 1-12	5 (33.3)	5 (31.2)	3 (20.0)
Grades 13-16	8 (53.3)	9 (56.2)	8 (53.3)
Grades >16	2 (13.3)	2 (12.5)	4 (26.7)
	Mean (SD)	Mean (SD)	Mean (SD)
Age	66.4 (11.3)	67.5 (10.3)	66.0 (10.2)
Type of Cancer Treatment
Surgery, radiation & chemotherapy	10 (71.4)	9 (60.0)	12 (80.0)
Surgery & radiation	2 (14.3)	4 (26.7)	2 (13.3)
Surgery & chemotherapy	1 (7.1)	2 (13.3)	1 (6.7)
Surgery	1 (7.1)	0 (0.0)	0 (0.0)
	Median [IQR]	Median [IQR]	Median [IQR]
Time from surgery to lymphedema diagnosis (months)	7.2 [4,27]	14.8 [5,108]	30.0 [2,84]
Lymphedema duration (months)	27.0 [6,58]	18.9 [5,73]	25.2 [6,142]
	Mean (SD)	Mean (SD)	Mean (SD)
Age at lymphedema diagnosis (years)	61.6 (9.9)	63.9 (10.7)	58.6 (11.0)
Location of lymphedema
Left	10 (66.7)	10 (62.5)	5 (33.3)
Right	5 (33.3%)	6 (37.5%)	10 (66.7)
Stage of lymphedema
I	1 (6.7)	3 (18.8)	0 (0.0)
II	14 (93.3)	12 (75.0)	14 (93.3)
III	0 (0.0)	1 (6.2)	1 (6.7)

^*p <.05